Gastro dny 2020

Preliminary Detailed Programme

Thursday 3 December 2020

 

09:00–10:30  

Postgraduate Session 1

B1+B2
  Diagnosis and Management of Functional Chest Pain
Ronnie Fass, USA
 
  Improving Neoplasia Detection Rate in Barrett's Esophagus
Prateek Sharma, USA
 
  H. pylori Treatment Strategies
Henry Cohen, Uruguay
 
  TBA  
  TBA  
 

09:00–10:30  

Plenary Session

C1+C2
 

09:00–10:30  

Gut Microbiota in Gastrointestinal Health and Disease

D8+D9
  TBA  
  Microbiota and Immune System
Miloslav Kverka, Czech Republic
 
  TBA  
  TBA  
  Intestinal Microbiota in IBS
Mirjana Rajilić-Stojanović, Serbia
 
 

09:00–10:30  

HCV Treatment as the Way to Elimination

D6+D7
  TBA  
  DAAs as the Way to Global HCV Elimination
Alessandra Mangia, Italy
 
  The Burden of HCV and HIV Coinfection
Robert Flisiak, Poland
 
  Metabolic Changes in Chronic HCV Infection
Peter Jarcuska, Slovakia
 
  Improving Quality of Life after DAA Treatment
Michael Makara, Hungary
 
 

09:00–10:30  

Free papers 1

D3
 

09:00–10:30  

Free papers 2

D4
 

10:30–11:00  

Coffee break

 
 

11:00–12:30  

Postgraduate Session 2

B1+B2
  Non-responsive Celiac Disease
David Sanders, UK
 
  Management of Small Bowel Polyps
Jean-Christophe Saurin, France
 
  Fecal Incontinence: Rome IV Criteria and Treatment
Magnus Simren, Sweden
 
  Critical Issues in Diverticular Disease
Dan Dumitrascu, Romania
 
  TBA  
 

11:00–12:30  

GI Oncology: Where Are We Going?

C1+C2
  TBA  
  Individualized Therapy of GI Cancer: What is Here and What is to Come?
Joseph Sung, China
 
  TBA  
  Neoadjuvant Therapy for Operable Cancer: A Paradigm Shift?
Thomas Seufferlein, Germany
 
  TBA  
 

11:00–12:30  

Gut in Motion: News from Upper GI Motility Disorders

D8+D9
  TBA  
  How to Diagnose and Classify Esophageal Motility Disorders
Mark Fox, UK
 
  How to Diagnose Gastroparesis – Scintigraphy, Capsule, Breath Test of Endoflip?
Zuzana Vacková, Czech Republic
 
  TBA  
  Endoscopic Treatment for Esophageal and Gastric Motility Disorders
Marcel Tantau, Romania
 
 

11:00–12:30  

Changing Face of Viral Hepatitis

D6+D7
  TBA  
  Current Treatment Options of Hepatitis Delta Infection
Cihan Yurdaydin, Turkey
 
  Current Insight in HBV Reactivation
Daniel Shouval, Israel
 
  Increasing Burden of HEV Infection
Krzysztof Tomasiewicz, Poland
 
  TBA  
 

11:00–12:30  

Free papers 3

D3
 

11:00–12:30  

Free papers 4

D4
 

12:30–13:30  

Lunch / Lunch Symposium

 
 

13:30–15:00  

Postgraduate Session 3

B1+B2
  TBA  
  Vaccination in Patients with IBD
Gerhard Rogler, Switzerland
 
  TBA  
  TBA  
  Endoscopic treatment of Acute Pancreatitis
Tomáš Hucl, Czech Republic
 
 

13:30–15:00  

CGS Session 1 – Onemocnění jater (in Czech)

C1+C2
 

13:30–15:00  

Early Esophageal Cancer – Recent Advances

D8+D9
  Diagnosis and Staging of Early Esophageal Neoplasia and Premalignant Conditions
Peter Siersema, the Netherlands
 
  Indication for Endoscopic Treatment
Weusten Bas, the Netherlands
 
  Indication for Surgery
Tomáš Haruštiak, Czech Republic
 
  TBA  
  Case Based Panel Discussion  
 

13:30–15:00  

Up-to date Approach to Biliary Stricture

D6+D7
  Brush and FISH First
Urban Arnelo, Sweden
 
  Cholangioscopy First
Yong Moon, South Korea
 
  EUS First
Ondřej Urban, Czech Republic
 
  TBA  
  Stents
Petr Vítek, Czech Republic
 
 

13:30–15:00  

Free papers 5

D3
 

13:30–15:00  

Free papers 6

D4
 

15:00–15:30  

Coffee break

 
 

15:30–17:00  

Postgraduate Session 4

B1+B2
  Biliary Endoscopy in the Management of Primary Sclerosing Cholangitis and Its Complications
Nageshwar Reddy, India
 
  TBA  
  Screening in HCC
Guilherme Macedo, Portugal
 
  New biomarkers in the management of viral hepatitis
Cihan Yurdaydin, Turkey
 
  Autoimmune Liver Disease
Joost Drenth, the Netherlands
 
 

15:30–17:00  

CGS Session 2 – Onemocnění pankreatu a žlučových cest (in Czech)

C1+C2
 

15:30–17:00  

IBD and Other Immune-mediated Inflammatory Disorders

D8+D9
  TBA  
  TBA  
  Therapeutic Consequences of IMID in IBD Patients
Milan Lukáš, Czech Republic
 
  TBA  
  IMID or Extraintestinal Manifestation of IBD?
Tamás Molnár, Hungary
 
 

15:30–17:00  

Acute Pancreatitis

D6+D7
  Patomechanism of AP: A Critical Appraisal of Clinical Relevance
Jason Bruce, UK
 
  TBA  
  TBA  
  TBA  
  TBA  
 

15:30–17:00  

Free papers 7

D3
 

15:30–17:00  

Free papers 8

D4
 

17:00–18:00  

Opening Ceremony

B1+B2

 

© 2019–2020 GUARANT International spol. s r. o.